Exelixis
EXEL
#1823
Rank
ยฃ8.35 B
Marketcap
ยฃ31.18
Share price
1.11%
Change (1 day)
9.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company